The practical synthesis of a novel and highly potent analogue of bryostatin
Related Experiment Video
Updated: Jan 13, 2026

Synthesis of a Borylated Ibuprofen Derivative Through Suzuki Cross-Coupling and Alkene Boracarboxylation Reactions
Published on: November 30, 2022
Paul A Wender1, Jeremy L Baryza, Chad E Bennett
1Department of Chemistry, Stanford University, Stanford, California 94305-5080, USA. wenderp@stanford.edu
Abstract:
Macrocycle 1 is a new highly potent analogue of bryostatin 1, a promising anti-cancer agent currently in human clinical trials. In vitro, 1 displays picomolar affinity for PKC and exhibits over 100-fold greater potency than bryostatin 1 when tested against various human cancer cell lines. Macrocycle 1 can be generated in clinically required amounts by chemical synthesis in only 19 steps (LLS) and represents a new clinical lead for the treatment of cancer.
Related Concept Videos
Synthesis of α-Substituted Carbonyl Compounds: The Stork Enamine Reaction
Alkylation of β-Diester Enolates: Malonic Ester Synthesis

